Your browser doesn't support javascript.
loading
Molecular profiling of NOD mouse islets reveals a novel regulator of insulitis onset.
Mathisen, Andreas Frøslev; Vacaru, Andrei Mircea; Unger, Lucas; Lamba, Elena Mirela; Mardare, Oana-Ana-Maria; Daian, Laura Maria; Ghila, Luiza; Vacaru, Ana-Maria; Chera, Simona.
Afiliación
  • Mathisen AF; Department of Clinical Science, Mohn Research Center for Diabetes Precision Medicine, University of Bergen, Bergen, Norway.
  • Vacaru AM; BetaUpreg Research Group, Institute of Cellular Biology and Pathology "Nicolae Simionescu", Bucharest, Romania.
  • Unger L; Department of Clinical Science, Mohn Research Center for Diabetes Precision Medicine, University of Bergen, Bergen, Norway.
  • Lamba EM; BetaUpreg Research Group, Institute of Cellular Biology and Pathology "Nicolae Simionescu", Bucharest, Romania.
  • Mardare OA; BetaUpreg Research Group, Institute of Cellular Biology and Pathology "Nicolae Simionescu", Bucharest, Romania.
  • Daian LM; BetaUpreg Research Group, Institute of Cellular Biology and Pathology "Nicolae Simionescu", Bucharest, Romania.
  • Ghila L; Department of Clinical Science, Mohn Research Center for Diabetes Precision Medicine, University of Bergen, Bergen, Norway.
  • Vacaru AM; BetaUpreg Research Group, Institute of Cellular Biology and Pathology "Nicolae Simionescu", Bucharest, Romania. Ana.Vacaru@icbp.ro.
  • Chera S; Department of Clinical Science, Mohn Research Center for Diabetes Precision Medicine, University of Bergen, Bergen, Norway. Simona.Chera@uib.no.
Sci Rep ; 14(1): 14669, 2024 06 25.
Article en En | MEDLINE | ID: mdl-38918575
ABSTRACT
Non-obese diabetes (NOD) mice are an established, spontaneous model of type 1 diabetes in which diabetes develops through insulitis. Using next-generation sequencing, coupled with pathway analysis, the molecular fingerprint of early insulitis was mapped in a cohort of mice ranging from 4 to 12 weeks of age. The resulting dynamic timeline revealed an initial decrease in proliferative capacity followed by the emergence of an inflammatory signature between 6 and 8 weeks that increased to a regulatory plateau between 10 and 12 weeks. The inflammatory signature is identified by the activation of central immunogenic factors such as Infg, Il1b, and Tnfa, and activation of canonical inflammatory signaling. Analysis of the regulatory landscape revealed the transcription factor Atf3 as a potential novel modulator of inflammatory signaling in the NOD islets. Furthermore, the Hedgehog signaling pathway correlated with Atf3 regulation, suggesting that the two play a role in regulating islet inflammation; however, further studies are needed to establish the nature of this connection.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Transducción de Señal / Islotes Pancreáticos / Ratones Endogámicos NOD / Diabetes Mellitus Tipo 1 / Factor de Transcripción Activador 3 Límite: Animals Idioma: En Revista: Sci Rep Año: 2024 Tipo del documento: Article País de afiliación: Noruega

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Transducción de Señal / Islotes Pancreáticos / Ratones Endogámicos NOD / Diabetes Mellitus Tipo 1 / Factor de Transcripción Activador 3 Límite: Animals Idioma: En Revista: Sci Rep Año: 2024 Tipo del documento: Article País de afiliación: Noruega